date:Nov 05, 2012
ines of the inauguration of the Nestle Institute of Health Sciences, said the Pfizer integration was on track and could be completed in about a month.
Nestle declined comment on whether the deal had been approved in other countries or regions.
Analysts have said the company may have to sell up to 30 percent of the Pfizer businesses, including those in Latin America, the Middle East and Asia, as part of an approval process which may take up to 12 months.
We are pleased that Nestle's acquisitio